Key facts
- It has raised $2.3M; the latest was Early Stage VC ($2.3M) in Jul 2025.
- Notable investors include Eleven Ventures, Sofia Angels Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Blue Longevity
- ·The full record, as it builds
Funding rounds
No funding rounds for Blue Longevity are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Blue Longevity
Operator of a longevity medicine clinic network intended to democratize access to preventive healthcare and extend healthspan through personalized, science-backed interventions. The company offers a fully integrated platform combining advanced diagnostics, regenerative therapies and AI-powered digital coaching, enabling customers to proactively manage aging, improve long-term health outcomes and adopt sustainable lifestyle changes through personalized care plans and microhabit formation.
- Sector
- Healthcare
- HQ
- Sofia, Bulgaria
- Founded
- 2024
- Website
- blue-longevity.com/
- Ownership
- Privately Held (backing)
Blue Longevity doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Blue Longevity shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Blue Longevity in its N-PORT filings yet. We sweep new filings monthly.